What is the current price and volume for OBSN.SW stock?

OBSN.SW stock is priced at **CHF0.0012** pre-market (30 Jan 2026) with volume **2,351,202**, roughly **3.48x** its average, reflecting elevated trading activity.

What grade does Meyka AI give OBSN.SW and what does it mean?

Meyka AI rates OBSN.SW **58.64 (C+)** with a suggestion to **HOLD**. The grade combines benchmark and sector comparisons, financial metrics and analyst signals; it is informational and not a recommendation.

What price does Meyka AI forecast for OBSN.SW stock?

Meyka AI's forecast model projects a base-case **CHF0.0100** (12 months), a conservative **CHF0.0025**, and a bull **CHF0.0500**. Forecasts are model outputs and are not guarantees.

What are the main risks for investors in OBSN.SW?

Key risks include clinical trial outcomes, funding dilution, and severe liquidity risk due to micro-cap status. Price swings may be extreme and driven by low-order-book depth.

CH Stocks

OBSN.SW ObsEva S.A. (SIX) CHF0.0012 pre-market 30 Jan 2026: most active with 2.35M vol

ByHuzaifa Zahoor January 30, 2026

OBSN.SW stock opened the pre-market on 30 Jan 2026 at CHF0.0012, after a sharp intraday drop from CHF0.0050, while volume surged to 2,351,202 shares. The move makes ObsEva S.A. (OBSN.SW) one of the most active names on the SIX pre-market tape. Traders are reacting to liquidity and historical volatility rather than fresh fundamentals. We summarise the trading picture, company metrics, Meyka AI grade and a short-term forecast to help frame risk and opportunity for Swiss biotech investors.